The results are expressed as Mean Fluorescent Intensity (MFI) and represent changes to the CD11b cellular surface expression in both monocytes and neutrophils, both pre-operatively (baseline) and after FURS (30, 120 and 240 min post-operatively), for the treatment of kidney stones. The gene discussed is ITGAM; the disease is nephrolithiasis.